We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
China Biologic Products Holdings, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced the completion of its merger with CBPO Group Limited, a wholly owned subsidiary of CBPO Holdings Limited , pursuant to ...
China Biologic Products Holdings, Inc., a leading fully integrated plasma-based biopharmaceutical company in China, today announced its unaudited financial results for the third quarter of 2020.